Currently, the leading cause of death in the U.S. is heart disease. Usually, the precursor leading to cardiovascular (CV) events in patients is hypertension. The current guidelines (JNC VIII) has a standard treatment goal of a systolic blood pressure <140 mmHg in order to prevent future CV complications. The purpose of this study is to compare the current standard treatment of the systolic blood pressure goal of <140 mmHg to a more intensive goal of <120 mmHg. We believe this study could be applied to this practice setting because it can possibly lead to a change in therapeutic blood pressure target goals. The study shows that there was a significant decrease of a 0.54% absolute risk reduction in rate of primary endpoints which included: myocardial infraction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes. It appears that the use of intensive treatment decreases the rate of CV events as compared to standard treatment. The result of this study can definitely have an impact on the development of future hypertension guidelines.
Non-peer reviewed information: This site assumes no responsibility or liability for the misinterpretation of the information provided. Furthermore, due to the vastness and ever changing nature of health-related information, we make no guarantee on the currency, reliability, completeness and accuracy of the information provided by our service or on other sites to which we provide links. We do not endorse any site nor are we responsible for the information contained in such sites. The information provided is not intended to diagnose or treat medical conditions and the information should not be used as a replacement for appropriate medical care and/or supervision.
Link to the full abstract review: NEJM Abstract Review 151111